Groups of 10 male and 10 female F344/N rats were exposed to 0, 31, 62.5, 125, 250, and 500 ppm of 2-butoxyethanol (BE) by inhalation, 6 hr/day, 5 days/wk, for 13 wk. Four moribund female rats from the 500 ppm group were sacrificed during the first 4 days of exposure, and 1 moribund female from the same group was sacrificed during week 5. Dark irregular mottling and/or loss of the distal tail were noted in sacrificed moribund rats. Similar gross lesions were noted in the terminally sacrificed females exposed to 500 ppm BE. Histologic changes noted in the day 4 sacrificed moribund rats included disseminated thrombosis involving the coccygeal vertebrae, cardiac atrium, lungs, liver, pulp of the incisor teeth, and the submucosa of the anterior section of the nasal cavity. Alterations noted in coccygeal vertebrae from the 500 ppm sacrificed moribund rats included ischemic necrosis and/or degeneration of bone marrow cells, bone-lining cells, osteocytes (within cortical and trabecular bone), and chondrocytes (both articular and growth plate), changes that are consistent with an infarction process. The moribund female rat that was sacrificed during week 5 and those female rats treated with 500 ppm and sacrificed following 13 wk of treatment lacked thrombi, but they had coccygeal vertebral changes consistent with prior infarction and transient or complete bone growth arrest. No bone lesions or thrombi were noted in the male rats treated with the same doses of BE. In conclusion, exposure to 500 ppm BE vapors caused acute disseminated thrombosis and bone infarction in female rats. Possible pathogenic mechanisms are discussed.
INTRODUCTION
2-Butoxyethanol (BE; ethylene glycol monobutyl ether) is a major environmental chemical that is utilized in the manufacturing of a wide range of domestic and industrial products. BE is used extensively in surface coatings and cleaners (as a chemical intermediate) and as a general solvent in various products, including household aerosols and cleaning agents (14) .
It is documented that BE causes acute hemolytic anemia in male and female rats and that metabolic activation of BE to 2-butoxyacetic acid (BAA) is required for the manifestation of this effect (4, 10, 11, 24) . Previous studies showed that the hematologic effects (i.e., reduction in erythrocytic number, hematocrit, and hemoglobin levels) are more severe in female than in male rats when using comparable dosages (4, 24) . The effects of BE on red blood cell (RBC) parameters are time and dose dependent. In earlier studies in which only male rats were used, it was shown that hemolysis caused by BE exposure is preceded by morphological changes in the erythrocytes, including stomatocytosis, spherocytosis, fragmentation, and formation of ghost cells (9, 39) . This suggests that the target of the hematotoxic metabolite of BE (i.e., BAA) is most likely the RBC membrane (9, 19) . Other changes noted in experiments in which only male rats were exposed to BE included secondary hemoglobinemic nephrosis and focal hepatocellular coagulative necrosis, associated with the presence of pigment-laden macrophages (10) . In other investigations, it was shown that daily dosing of male rats with BE beyond a period of 3 days resulted in tolerance to the development of hemolytic anemia (12) . In vivo and in vitro investigations of the mechanism(s) underlying this phenomena indicated that tolerance may be related to the lesser sensitivity of young erythrocytes formed during the regenerative process (9, 12) .
In addition, it has been shown that BAA-induced in vitro effects are species-dependent, with erythrocytes from rats, mice, hamsters, rabbits, and baboons being more sensitive to the hemolytic effect of BAA in vitro than are erythrocytes from humans, pigs, dogs, cats, and guinea pigs (13) . The mechanisms responsible for the species' differences in sensitivity are unknown. It was also shown that older rats are more susceptible to BEinduced hematotoxicity and associated pathology than are younger rats. It was suggested that this age-related difference in sensitivity may be related to a higher activation/detoxification index of BE, with BAA exhibiting a longer half-life in older rats (10) . The primary purpose of this report is to describe the vascular and bone lesions observed in moribund female rats sacrificed after exposure to 500 ppm BE by inhalation.
MATERIALS AND METHODS
Chemical. BE (>99~o pure) was supplied by Dow Chemical USA (Plauemine, LA). No impurities greater than 0.1 % were detected. Animals. F344/N rats of both sexes were obtained from Taconic (Germantown, NY) at 4-5 wk of age. After quarantine for 11-12 days, rats were randomly assigned to BE-exposure or control groups. Rats were housed individually in stainless-steel wire cages, and feed (NIH-07 open formula, Zeigler Bros., Gardners, PA) and water were available ad libitum, except during the exposure periods. The rats were observed twice daily and were weighed weekly. Animal husbandry and handling were conducted in accordance with NIH guidelines (15) . Inhalation Exposure of Rats to BE. This study was conducted at Battelle Pacific Northwest Laboratories.
Groups of 10 male and 10 female F344/N rats were exposed to target concentrations of 0, 31, 62.5, 125, 250, and 500 ppm BE by inhalation, 6 hr/day, 5 days/wk, for 13 wk. Control rats (10 animals/sex) were concurrently exposed to filtered air. The inhalation exposure chambers were maintained at a temperature of 21-27°C with 31-77% relative humidity, and the chambers were on a 12hr dark/light cycle. Cage units were periodically rotated within each chamber.
Necropsy and Tissue Handling. Rats were sacrificed using 70% C02 anesthesia followed by exsanguination. A complete necropsy and microscopic examination were performed on all rats found moribund or dead as well as on those that died at terminal sacrifice. Tissue samples and all gross lesions were collected and immersed in 10% neutral-buffered formalin for fixation. Bones were decalcified in 10% formic acid prior to processing. Tissues were then processed, embedded in paraffin, sectioned at 5-6 f.1m, and stained with hematoxylin and eosin for microscopic examination (3) . The tails were cut longitudinally. Hematological analyses were not performed on interim-sacrificed rats but were performed on the terminally sacrificed rats (25) .
RESULTS
Five moribund females from the 500 ppm group (4 on the fourth day of exposure and another 1 during week 5) were sacrificed during the study. Clinical signs included abnormal breathing, pallor, red urine stains, nasal and eye discharge, lethargy, and increased salivation and/or lacrimation. Lesions, which consisted of alternating bands of dark purplish blue with blanched white bands in approximately the distal one-third of the tail, were noted in all females exposed to 500 ppm BE. In 2 of the sacrificed moribund rats and in all female rats exposed to 500 ppm that survived beyond the 4 days of treatment, tail necrosis progressed to sloughing and/or self-mutilation of this portion of the tail. The most consistent histopathological changes noted in the day 4 sacrificed moribund female rats exposed to 500 ppm BE included the following locations of thrombosis: cardiac atrium ( Fig. 1 ); pulmonary vessels (Fig. 2) ; submucosal blood vessels of the most anterior section of the nasal septum ( Fig. 3 ); dental pulp blood vessels, associated with focal odontoblast degeneration ; and hepatic central veins, occasionally associated with adjacent hepatocellular necrosis (Fig. 4 ). The vascular thrombi were occlusive and consisted of amorphous granular material or partly organized fibrin with varying numbers of red blood cells.
Lesions consistent with acute infarction were noted in the coccygeal vertebrae of the day 4 rats, which were moribund sacrificed. Histopathological changes involved bone marrow cells, bone-lining cells (including resting and active osteoblasts), osteocytes within cortical and trabecular bone, and chondrocytes of both articular and growth plate cartilage (Figs. 5 and 6). Bone-lining cells and osteocytes within cortical and trabecular bone exhibited nuclear pyknosis and/or fragmentation to complete loss of nuclear staining, often appearing as ghost cells. Some osteocyte lacunae were empty. Growth plate and articular cartilage also exhibited loss of individual cells and/or loss of nuclear and matrix staining, which is consistent with acute infarction. Thrombi were noted in large vessels of the tail as well as in intramedullary and periosteal blood vessels. Small thrombi were also noted within metaphyseal vessels of the femur, but there was no evidence of necrosis.
In the moribund female rat that was exposed to 500 ppm BE and sacrificed at week 5, additional changes noted in the coccygeal vertebrae included marrow inflammation and the presence of growth arrest lines ( Fig. 7 ). There was no evidence of necrosis on the growth plate side of the growth arrest line, whereas on the diaphyseal side of the growth arrest line, there was evidence of widespread marrow and bone infarction. Affected bone marrow was infiltrated by macrophages (foreign body-type inflammation) in response to fat necrosis. No thrombi were noted in the marrow spaces.
Thrombi were not observed in any female rats sacrificed at the end of the 13-wk exposure to 500 ppm BE.
However, coccygeal bone lesions consistent with prior infarction and transient or complete growth arrest were observed. Within the most severely affected vertebrae, there was diffuse growth plate degeneration, with no evidence of renewed longitudinal growth (Figs. [8] [9] [10] .
These vertebrae exhibited bone marrow necrosis that extended to the growth plate, capping of the growth plate with a dense layer of bone, and degeneration of growth plate cartilage. In many areas, infarcted bone (metaphyseal and cortical) was irregularly marginated by new viable bone, which was deposited on the surface of dead bone (Fig. 11 ). Other infarcted bone trabeculae were surrounded by fibrous connective tissue. Also noted were prominent bone marrow (fat) necrosis and secondary foreign body-type inflammation that extended to the growth plate.
Less severely affected vertebrae contained single growth arrest lines within the metaphysis. These lines were irregular in shape and/or contour, were often incomplete, and sometimes contained cartilage. Bone and marrow necrosis were restricted to the diaphyseal side of the growth arrest line and were absent in the region between the growth plate and the growth arrest line, resulting in a zonal pattern of necrosis. Some vertebrae had focal irreversible growth plate defects. These focal growth plate defects appeared &dquo;pulled-apart&dquo; from the growth plate because they were left behind as the viable regions resumed longitudinal growth (Fig. 12 ). Bone marrow inflammation in response to previous fat necrosis, deposition of newly viable bone marginating infarcted bone, and peritrabecular fibrosis occurred to varying degrees in different vertebrae.
Other lesions noted in the moribund female rats that were sacrificed during the study included atrophy of the spleen and thymus; inflammation, necrosis, ulceration, and hyperplasia of the forestomach; centrilobular degeneration of the liver; and hemoglobinuric nephrosis. All male rats that survived until the end of the study lacked evidence of bone or vascular injury. Hematologic analyses revealed a macrocytic, normochromic, and regenerative anemia that was more severe among the females (25) .
DISCUSSION
A distinctive pathological finding in the present study was the presence of widespread thrombi in moribund female rats that were sacrificed early in the study. Acute bone infarction was also noted in the same animals. Various mechanisms that may be involved in the pathogenesis of chemically induced thrombosis were proposed, and they include the following: vascular damage, induction of hypercoagulable state (i.e., shift in the hemostatic equilibrium due to intravascular hemolysis), and disturbance of blood flow (44) .
Disseminated thrombosis, such as that noted in disseminated intravascular coagulation (DIC) or consumption coagulopathy, is a thrombohemorrhagic disorder that may develop as a complication in a variety of diseases in human patients and animals (1, 6, 20) . DIC may be triggered by the release of procoagulant tissue factor(s) into the circulation following injury (e.g., in obstetric accidents, certain neoplasms, etc.) or following widespread endothelial injury and resulting surface contact with collagen and activation of factor XII. The thrombi may be formed in the general circulation or may be localized to a specific organ and tissue. The thrombi depositions may lead to ischemia of the more severely affected or more vulnerable organs (6) . BE-induced alterations in erythrocytic morphology, decreased erythrocyte deformability, and subsequent intravascular hemolysis may potentially lead to the disseminated thrombosis noted in female rats exposed to 500 ppm BE. BE is a potent acute hemolytic agent in rats, and females are more susceptible to it than are males. -Coccygeal vertebra from a control female F344/N rat exposed to filtered air for 13 wk. The growth plate (GP) is present, but endochondral ossification and longitudinal growth have ceased at this age. The growth plate is capped with a thin layer of bone (arrow). The bone marrow contains mostly fat. H&E. X 124.
Since thrombosis was observed in female rats only, it is likely that BE-induced intravascular hemolysis may play a role in the pathogenesis of thrombosis. Thrombosis has been observed in many hemolytic situations, including the following: immediate hemolytic transfusion reactions, inherited hemolytic disorders characterized by predominantly intravascular red cell destruction, and paroxymal nocturnal hemoglobinuria (PNH) (21, 40, 41) . In patients with PNH, the striking predisposition to intravascular thrombosis accounts for about 50% of deaths. Thromboses were noted in the portal system, brain, extremities, and elsewhere. In PNH, the liberation of thromboplastic factors from hemolyzed RBCs has been suggested to play a role in the increased tendency for thrombosis. In a mouse model of hereditary spherocytosis, infarctions were documented in the heart, brain, spleen, and liver that did not always correlate with thrombosis in the heart (21) . It was further suggested that the infarction was caused by peripheral emboli or intravascular thrombosis attributable to the release of procoagulants from the altered erythrocytes. It has been documented that single intravenous injections of monocrotaline pyrrole (MCTP) into rats specifically caused pulmonary vascular thrombosis (2, 33) .
Direct endothelial damage leading to thrombosis may be caused by localized inflammation and endothelial damage following injection of cytotoxic substances into the blood vessels or its surroundings (23, 44) . Although there is no experimental evidence suggesting that direct endothelial cell damage is caused by BE, it is premature to discount this mechanism at this time. Additionally, since no thrombosis was observed in male rats exposed to BE, it is unlikely that this mechanism was involved, unless direct vascular damage by BE is also gender dependent and occurs in female rats only.
Disturbed blood flow secondary to changes in various rheological factors may also be involved in the BE-induced disseminated thrombosis. BE is known to cause FIG. 9.-Coccygeal vertebra from a F344/N rat exposed to 500 ppm 2-butoxyethanol for 13 wk. A thin remnant of nonviable growth plate (GP) is capped with thick layer of bone (B) and fibrous connective tissue (CT). Bone marrow necrosis and inflammation extend to the CT (see Fig. 10 ). Fig. 9 . The bone marrow is infiltrated with macrophages (some multinucleated) in response to fat necrosis. H&E. X 500.
FIG. 11.-Coccygeal vertebra from a female F344/N rat exposed to 500 ppm 2-butoxyethanol for 13 wk. Necrotic bone lacks osteocytes and is irregularly marginated by new viable bone (arrows). The bone marrow is irregularly infiltrated with macrophages in response to fat necrosis. H&E.
X500.
FIG. 12.-Coccygeal vertebra from a female F344/N rat exposed to 500 ppm 2-butoxyethanol for 13 wk. Focal growth plate (GP) degeneration followed by renewed endochondral ossification has resulted in a transverse segment (TS) of cartilage and bone that was left behind as the viable growth plate cartilage moved away. H&E. X 124. altered erythrocyte morphology and deformability. Udden and Paton (37) demonstrated that rat erythrocytes exposed in vitro to BAA had a marked decrease in deformability (increased rigidity) and morphological changes, including spherocytosis, spheroechinocytosis, and a tendency for erythrocytes to adhere to one another. Examination of blood smears obtained from rats treated with BE showed that there were significant morphological alterations affecting erythrocytes (9, 39) . These morphological alterations may lead to decreased erythrocyte deformability and other rheological changes, resulting in erythrostasis and, eventually, disseminated thrombosis (31) . The viscosity of oxygenated blood from patients with sickle cell anemia (SCA), in which disseminated thrombosis is a frequent complication, was found to be abnormally increased and was mainly attributed to the altered rheological factors (i.e., increased erythrocytic internal viscosity, reduced membrane flexibility, and increased tendency of &dquo;sickled&dquo; cells to aggregate) (5) .
Bone necrosis is infrequently reported in rats (35, 36, 42, 43) . Aside from rare idiopathic forms of bone necrosis, known causes of bone necrosis in rats include experimental exposure to radiation, fracture, and infection (especially following surgical procedures). Vascular thrombosis and subsequent infarction apparently caused the bone lesions that were noted in this study. This is supported by the presence of fibrin thrombi within blood vessels that supply the tail and coccygeal vertebrae coupled with acute ischemic bone necrosis, which affected multiple coccygeal vertebrae of rats that experienced early death. Loss of the distal portion of the tail was reported in rats exposed to 250 and 500 ppm of BE; however, no histological description was included (26) . Necrosis of the tail was recently described in rats treated with the antineoplastic drug S-l, which caused severe anemia and an increase in platelet count and fibrinogen (16) .
In our study, rats that survived to terminal sacrifice also displayed evidence of bone infarction of coccygeal vertebrae, but the pattern of involvement indicated that the ischemic episode occurred early in the study. Surviv-ing animals apparently experienced vascular thrombosis and infarction, since there was clear evidence of renewed longitudinal growth. This latter finding is consistent with the observed reversible growth plate injury. The occurrence of such a phenomenon is supported by the presence of the following alterations in the surviving animals: presence of growth arrest lines within the metaphysis of many vertebrae; presence of bone marrow necrosis on the diaphyseal side of the growth arrest line; and the absence of bone marrow necrosis on the growth plate side of the growth arrest lines. Marrow between the arrest line and the growth plate was unaffected, because it formed after the insult that caused the necrosis. Also noted were renewed bone formations along nonviable bone (known as &dquo;creeping substitution&dquo;) (32) and marrow foreign bodylike inflammation in response to fat necrosis. These findings are indicators of ischemic injury followed by recovery.
The presence of single growth arrest lines (some with remnants of growth plate cartilage) at the end of each coccygeal vertebra of terminally sacrificed rats is also consistent with a single ischemic insult. The space between the arrest line and the growth plate represents the period of time between resumption of longitudinal growth and terminal sacrifice. The greater the distance between the growth arrest line and the growth plate, the greater the time between the ischemic insult and terminal sacrifice. Growth arrest lines are usually formed during bone ischemia and/or infarction as a result of transient slowing or temporary cessation of longitudinal growth (28) . This permits bone to be deposited on the surface of metaphyseal trabeculae (usually just adjacent to the growth plate) for a longer-than-usual period of time. Growth arrest lines are eventually remodeled, and, hence, they become irregular and/or contour shaped or are completely absent in some vertebrae.
In the most severely affected vertebrae, there was no evidence of renewed longitudinal growth, which indicated irreversible growth plate injury. Focal irreversible growth plate defects were also noted in several coccygeal vertebrae. Apparently, when blood flow and growth were reinitiated in these vertebrae, transverse segments of cartilage and bone were left behind as the viable growth plate cartilage moved away from them. Very few diseases/conditions are known to present with clinicopathologic features of hemolytic disease coupled with both thrombosis and bone infarction. SCA is the prototype of hereditary hemoglobinopathies, characterized by the production of structurally abnormal hemoglobin (6) . One of the pathological complications of this disease is vascular occlusion. It has been proposed that the pathogenesis of this microvascular occlusion, once thought to be the result of the impaction of nondeformable sickled cells in capillaries and venules, is caused by abnormalities of charge and organization of phospholipids in the red cell membrane (6, 29) . These changes increase the adhesiveness of the RBC to the endothelium and ultimately may result in a narrowing of the microvessels. The erythrostasis leads to thrombosis, or at least to marked tissue hypoxia. Although the underlying defect leading to hemolytic anemia in the BE-exposed rats and in humans suffering from sickle cell disease may differ, in both species there are some common clinicopathological features, including the occurrence of acute disseminated thrombosis and bone infarction. In patients with sickle cell anemia, the skeleton is a frequent target (34) . Bone complications noted to accompany this disease include bone marrow necrosis, bone infarcts, osteomyelitis, and aseptic necrosis. Bone infarcts associated with sickle cell disease have been described in the skull (30) , articulations (18) , spinal cord (8), long bones, and ilia (22) . Bone changes associated with soft tissue ulceration were also described (27) . It was suggested that in human patients suffering from sickle cell anemia, massive fat and necrotic bone marrow embolization may occur, with subsequent spread into the general circulation, eventually leading to death (8, 17, 38) . In those cases, evidence for DIC was also present (8).
Since thrombosis and bone infarction were not observed in male rats similarly treated with BE, it was concluded that females were more susceptible to these effects of BE than were male rats. Studies investigating genderrelated differences in the hematotoxic effects of BE also indicated that the onset of hemolysis was faster and significantly more severe in females (4) . These sex-related differences in BE-induced toxicity in rats may be attributed to differences in the toxicokinetics of BAA (the toxic metabolite of BE) (7) . Recent studies demonstrated that females are less efficient in eliminating BAA, as is evident by the relatively longer half-life (tl/2), the greater area under the plasma concentration versus time curve, and the greater maximum plasma concentration in female rats (7) . In the present study, in female rats exposed to 500 ppm BE, a critical damage was likely induced (i.e., vascular damage, hypercoagulation state, and/or disturbances of blood flow), which triggered microthrombi formation and occlusion of the blood vessels and subsequent infarction. Previous work showed that daily dosing of BE in male rats results in the development of tolerance toward the hemolytic effect beyond 3 days of dosing (12) . It may be suggested that with the development of tolerance to the hemolytic effect of BE, no additional bone lesions developed. This is consistent with a lack of thrombi in terminally sacrificed rats.
In conclusion, BE has the potential to cause disseminated thrombosis and bone infarction in female rats. Although the pathogenesis of the BE-induced disseminated thrombosis is currently unknown, it is likely that BEinduced hemolysis (with potential release of protocoagulant factors from destroyed erythrocytes) may result in disturbances of blood flow and, subsequently, in thrombosis. The greater sensitivity of female (vs male) rats to BE-induced hemolysis is consistent with and supports the hypothesis that the thrombosis and bone infarction observed in female rats (but not in male rats) are triggered by the more severe hemolytic anemia observed in this gender. However, other mechanisms, such as direct endothelial cell damage by BE, may not be excluded at this time.
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The first conference on Endocrine Modulating Circumstances: Health and Environmental Perspectives will be held at the Marriott Hotel in Tysons Corner, Virginia, October 21-23, 1999. Endocrine modulating circumstances include exposure to endocrine mimicking chemicals, anthropogenic physico-chemical changes (e.g., changes in pH or temperature), and natural environmental conditions that can modulate endocrine function. The conference will promote the exchange of ideas and opinions among scientists working on the analysis, screening, monitoring, exposure assessment, and research of endocrine modulators and on the geologic and hydrologic environments in which they operate. The conference will explore current and future directions of health and ecological impacts of endocrine modulating circumstances. To facilitate this interaction, the program will include keynote speakers and plenary, concurrent, and poster sessions.
Topics will include: Organ-related pathology/toxicology of endocrine modulating compounds, ecological circumstances affecting endocrine modulation, chemical structural diversity (including mimics) of endocrine modulating compounds, mechanism(s) of action and effect of endocrine modulating compounds, endpoints and specific &dquo;sen-tinel&dquo; species (both flora and fauna) for endocrine modulating compounds, clinical outcomes/biomarkers of exposure, testing methods in clinical studies of endocrine modulating compounds, and testing (field/lab) methods for endocrine modulating compounds.
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